Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain

The glutamatergic theory of schizophrenia proposes a dysfunction of ionotropic N-methyl-d-aspartate receptors (NMDA-R). Several therapeutic strategies address NMDA-R function and the effects of antipsychotic agents on NMDA-R expression have been described. Within the second-generation antipsychotics...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Segnitz, Nina (VerfasserIn) , Ferbert, Thomas (VerfasserIn) , Schmitt, Andrea (VerfasserIn) , Gass, Peter (VerfasserIn) , Gebicke-Härter, Peter J. (VerfasserIn) , Zink, Mathias (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 12 April 2011
In: Psychopharmacology
Year: 2011, Jahrgang: 217, Pages: 127-142
ISSN:1432-2072
DOI:10.1007/s00213-011-2262-z
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00213-011-2262-z
Volltext
Verfasserangaben:Nina Segnitz, Thomas Ferbert, Andrea Schmitt, Peter Gass, Peter J. Gebicke-Haerter, Mathias Zink
Beschreibung
Zusammenfassung:The glutamatergic theory of schizophrenia proposes a dysfunction of ionotropic N-methyl-d-aspartate receptors (NMDA-R). Several therapeutic strategies address NMDA-R function and the effects of antipsychotic agents on NMDA-R expression have been described. Within the second-generation antipsychotics, the partial dopaminergic and serotonergic agonist aripiprazole (APZ) was able to counteract the behavioral effects of NMDA-R antagonists.
Beschreibung:Gesehen am 31.10.2022
Beschreibung:Online Resource
ISSN:1432-2072
DOI:10.1007/s00213-011-2262-z